E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction

Genes and Development

Volumn 11, Issue 14, 1997, Pages 1840-1852

  Hsieh, Jung Kuang ^a   Fredersdorf, Steffen ^a   Kouzarides, Tony ^b   Martin, Klause ^b   Lu, Xin ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Apoptosis; E2F1 overexpression; p53; Rb; Transactivation

Indexed keywords

DNA BINDING PROTEIN; PROTEIN P53;

APOPTOSIS; ARTICLE; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DNA BINDING; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

EID: 0030850752     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.14.1840     Document Type: Article

References (38)

1. An, B. and P.Q. Dou. 1996. Cleavage of retinoblastoma protein during apoptosis: An interleukin lb-converting enzyme-like protease as candidate. Cancer Res. 56: 438-442.
2. Berry, D.E., Y. Lu, B. Schmidt, P.C. Fallon, C. O'Connell, S.-X. Hu, H.-J. Xu, and G. Blank. 1996. Retinoblastoma protein inhibits IFN-γ induced apoptosis. Oncogene 12: 1809-1819.
3. Browne, S.J., A.C. Williams, A. Hague, A.J. Butt, and C. Paraskeva. 1994. Loss of APC protein expression by human colonic epithelial cells and the appearance of a specific lowmolecular-weight form is associated with apoptosis in vitro. Int. J. Cancer 59: 56-64.
4. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1991. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
5. Fan, G.-S., X.-M. Ma, B. Kren, and C.J. Steer. 1996. The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hetatoma cells. Oncogene 12: 1909-1919.
6. Field, S.J., F.Y. Tsai, F. Kuo, A.M. Zubiaga, J.W.G. Kaelin, D.M. Livingston, S.H. Orkin, and M.E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561.
7. Haas-Kogan, D.A., S.C. Kogan, D. Levi, P. Dazin, A. T'Ang, Y.-K.T. Fung, and M.A. Israel. 1995. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14: 461-472.
8. Hagemeier, C., A. Cook, and T. Kouzarides. 1993. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res. 21: 4998-5004.
9. Hateboer, G., R.M. Kerkhoven, A. Shvarts, R, Bernards, and R,L. Beijersbergen, 1996. Degradation of E2F by the ubiquitinproteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes &. Dev. 10: 2960-2970.
10. Haupt, Y., S. Rowan, and M. Oren. 1995. p53-mediated apoptosis in Hela cells can be overcome by excess pRb. Oncogene 10: 1563-1571.
11. Haupt, Y., Y. Barak, and M. Oren. 1996. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15: 1596-1606.
12. Hiebert, S.W., G. Packham, O.K. Strom, R. Haffner, M. Oren, G. Zambetti, and J.L. Cleveland. 1995. E2F1:DP-1 induced p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol. 15: 6864-6874.
13. Hijmans, E.M., P.M. Voorhoeve, R.L. Beijersbergen, L.J. Van'T Veer, and R. Bernards. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15:3082-3089.
14. Hofmann, F., F. Martelli, D.M. Livingston, and Z. Wang. 1996. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteosome pathway. Genes & Dev. 10: 2949-2959.
15. Johnson, D.G., J.K. Schwarz, W.D. Cress, and J.R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349-352.
16. Johnson, D.G., W.D. Cress, L. Jakoi, and J.R. Nevine. 1994. Oncogenic capacity of E2F1 gene. Proc. Natl. Acad. Sci. 91: 12823-12827.
17. Kowalik, T.F., J. DeGregori, J.K. Shwarz, and J. Nevins. 1995. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. Virology 69:2491-2500.
18. Krek, W., G.-F. Xu, and D.M. Livingston. 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83: 1149-1158.
19. Lam, E.W.-F. and N.B. La Thangue. 1994. DP and E2F proteins: Coordinating transcription with cell cycle progression. Curr. Opin. Cell Biol. 6: 859-866.
20. Martin, K., D. Trouche, C. Hagemeier, T.S. Sorensen, N.B. La Thangue, und T. Kouzarides. 1995. Stimulation of E2F1/DP1 transcriptional activity by mdm2 oncoprotein. Nature 375:691-694.
21. Nip, J.S., D.K. Strom, B.E. Fee, G. Zambetti, J.L. Cleveland, and S.W. Hiebert. 1997. E2F1 cooperates with topoisomerase II inhibitor and DNA damage to selectively agument p53-in-dependent apoptosis. Mol. Cell Biol 17: 1049-1056.
22. O'Connor, D.J., E.W.-F. Lam, S. Griffin, S. Zhong, L.C. Leighton, S.A. Burhidge, and X. Lu. 1995. Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1. EMBO J. 14: 6184-6192.
23. Phillips, A.C., S. Bates, K.M. Ryan, K. Helin, and K.H. Vousden. 1997. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes & Dev. (this issuel).
24. Qin, X.Q., D.M. Livingston, W.G.J. Kaelin, and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. 91: 10918-10922.
25. Rowan, S., R.L. Ludwig, Y. Haupt, S. Bates, X. Lu, M. Oren, and K.H. Vousden. 1996. Specific loss of apoptotic but not cellcycle arrest function in a human tumour derived p53 mutant. EMBO J. 15: 827-838.
26. Sardet, C., M. Vidai, D. Cobrinik, Y. Geng, C. Onufryk, and A. Chen. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phase of the cell cycle. Proc. Natl. Acad. Sci 92: 2403-2407.
27. Shan, B. and W.-H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell. Biol. 14: 8166-8173.
28. Shan, B., T. Durfee, and W.-H. Lee. 1996a. Disruption of RB/ E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl. Acad. Sci. 93: 679-684.
29. Shan, B., A.A. Farmer, and W.-H. Lee. 1996b. The molecular basis of E2F-1/DP-1 induced S-phase entry and apoptosis. Cell Growth Differ. 7: 689-697.
30. Shaw, S.B. and P. Tegtmeyer. 1981. Binding of dephosphorylated A protein to SV40 DNA. Virology 115: 88-96.
31. Singh, C.J., S.H. Wong, and W. Hong. 1994. Overexpression of E2F1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13: 3329-3338.
32. Weintraub, S.J., C.A. Prater, and D.C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259-261.
33. Weintraub, S.J., K.N.B. Chow, R.X. Luo, S. Zhang, S. He, and D.C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812-815.
34. Wu, X. and A.J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. 91: 3602-3606.
35. Wu, C.-L., L.R. Zukerberg, C. Ngwu, E. Harlow, and J.A. Lees. 1995. In vivo association of E2F and DP family proteins. Mol Cell. Biol. 15: 2536-2546.
36. Yamasaki, L., T. Jacks, R. Bronson, E. Goillot, E. Harlow, and N.J. Dyson. 1996. Tumour induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548.
37. Zacksenhaus, E., Z. Jiang, R.A. Phillips, and B. Gallie. 1996. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product. EMBO J. 15: 5917-5927.
38. Zhang, Y. and S.P. Chellappan. 1995. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogens 10: 2085-2093.